WallStreetZen

NASDAQ: REGN
Regeneron Pharmaceuticals Inc Stock

$652.00+6.85 (+1.06%)
Updated Sep 15, 2021
REGN Price
$652.00
Fair Value Price
$670.70
Market Cap
$69.73B
52 Week Low
$441.00
52 Week High
$686.62
P/E
11.07x
P/B
4.61x
P/S
4.74x
PEG
N/A
Dividend Yield
N/A
Revenue
$12.38B
Earnings
$6.21B
Gross Margin
86.8%
Operating Margin
58.94%
Profit Margin
50.1%
Debt to Equity
0.42
Operating Cash Flow
$2B
Beta
0.71
Next Earnings
Nov 3, 2021
Ex-Dividend
N/A
Next Dividend
N/A

REGN Overview

Zen Score

High
Medium
Low
49
Industry average

Reasons for this score

REGN ($652.00) is undervalued by 2.79% relative to our estimate of its Fair Value price of $670.70 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Valuation
REGN is good value based on its earnings relative to its share price (11.07x), compared to the US market average -8.74x)
Valuation
REGN is good value based on its earnings relative to its share price (11.07x), compared to the US Biotechnology industry average (280.41x)
Valuation

1 of 10

REGN News

Valuation

REGN fair value

Fair Value of REGN stock based on Discounted Cash Flow (DCF)
Price
$652.00
Fair Value
$670.70
Undervalued by
2.79%
REGN ($652.00) is undervalued by 2.79% relative to our estimate of its Fair Value price of $670.70 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Valuation

REGN price to earnings (PE)

For valuing profitable companies with steady earnings
Company
11.07x
Industry
280.41x
Market
-8.74x
REGN is good value based on its earnings relative to its share price (11.07x), compared to the US market average -8.74x)
Valuation
REGN is good value based on its earnings relative to its share price (11.07x), compared to the US Biotechnology industry average (280.41x)
Valuation

REGN price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
4.61x
Industry
6.98x
REGN is good value based on its book value relative to its share price (4.61x), compared to the US Biotechnology industry average (6.98x)
Valuation

REGN's financial health

Profit margin

Revenue
$5.1B
Net Income
$3.1B
Profit Margin
60.3%
REGN's Earnings (EBIT) of $7.30B can safely cover interest payments on company debt ($2.70B)
Financials
REGN's profit margin has increased (+9.7%) in the last year from (40.4%) to (50.1%)
Financials

Assets to liabilities

Assets
$21.5B
Liabilities
$6.4B
Debt to equity
0.18
REGN's short-term assets ($13.34B) exceed its short-term liabilities ($3.73B)
Financials
REGN's short-term assets ($13.34B) exceed its long-term liabilities ($2.63B)
Financials
REGN's debt relative to shareholder equity (0.42) has decreased or remained constant compared to 5 years ago (0.52)
Financials
REGN's debt to equity ratio (0.42) is considered high
Financials

Cash flow

Operating
$626.7M
Investing
$125.8M
Financing
-$118.2M
REGN's operating cash flow ($2.27B) is sufficient to service the company's debt ($2.70B)
Financials

Regeneron Pharmaceuticals Stock FAQ

What is Regeneron Pharmaceuticals's quote symbol?

(NASDAQ: REGN) Regeneron Pharmaceuticals trades on the NASDAQ under the ticker symbol REGN. Regeneron Pharmaceuticals stock quotes can also be displayed as NASDAQ: REGN.

What is the 52 week high and low for Regeneron Pharmaceuticals (NASDAQ: REGN)?

(NASDAQ: REGN) Regeneron Pharmaceuticals's 52-week high was $686.62, and its 52-week low was $441.00. It is currently -5.04% from its 52-week high and 47.85% from its 52-week low.

How much is Regeneron Pharmaceuticals stock worth today?

(NASDAQ: REGN) Regeneron Pharmaceuticals currently has 106,955,379 outstanding shares. With Regeneron Pharmaceuticals stock trading at $652.00 per share, the total value of Regeneron Pharmaceuticals stock (market capitalization) is $69.73B.

Regeneron Pharmaceuticals stock was originally listed at a price of $8.56 in Dec 31, 1997. If you had invested in Regeneron Pharmaceuticals stock at $8.56, your return over the last 23 years would have been 7,514.15%, for an annualized return of 20.73%.

How much is Regeneron Pharmaceuticals's stock price per share?

(NASDAQ: REGN) Regeneron Pharmaceuticals stock price per share is $652.00 today (as of Sep 15, 2021).

What is Regeneron Pharmaceuticals's Market Cap?

(NASDAQ: REGN) Regeneron Pharmaceuticals's market cap is $69.73B, as of Sep 16, 2021.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Regeneron Pharmaceuticals's market cap is calculated by multiplying REGN's current stock price of $652.00 by REGN's total outstanding shares of 106,955,379.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.